Services Agreements in the Biotechnology Industry

641 Contracts & Agreements

Browse by Company

2seventy bio, Inc. (3 contracts)
89bio, Inc. (1)
ACADIA PHARMACEUTICALS INC (8)
Accustem Sciences Inc. (1)
Acorda Therapeutics (11)
Acurx Pharmaceuticals, LLC (1)
Adagio Therapeutics, Inc. (3)
Adaptimmune Therapeutics PLC (5)
ADMA BIOLOGICS, INC. (7)
ADURO BIOTECH, INC. (1)
Advaxis, Inc. (3)
Adverum Biotechnologies, Inc. (2)
Aeglea BioTherapeutics, Inc. (5)
AGENUS INC (3)
AKCEA THERAPEUTICS, INC. (3)
Akebia Therapeutics, Inc. (4)
Allakos Inc. (1)
ALNYLAM PHARMACEUTICALS, INC. (2)
AMARIN CORP PLC (1)
Amgen Inc. (1)
AmpliPhi Biosciences Corp (1)
Amplitude Healthcare Acquisition Corp (2)
ANAVEX LIFE SCIENCES CORP. (10)
Aprea Therapeutics, Inc. (2)
Aptevo Therapeutics Inc. (2)
Aravive, Inc. (2)
Arbutus Biopharma Corp (1)
Arcellx, Inc. (1)
ARDELYX, INC. (2)
ARENA PHARMACEUTICALS INC (4)
Arsanis, Inc. (7)
Artiva Biotherapeutics, Inc. (3)
ARYA Sciences Acquisition Corp II (2)
Atara Biotherapeutics, Inc. (7)
Athenex, Inc. (1)
ATOSSA GENETICS INC (1)
Aurinia Pharmaceuticals Inc. (1)
AVROBIO, Inc. (1)
Axovant Sciences Ltd. (6)
BELLICUM PHARMACEUTICALS, INC (1)
BICYCLE THERAPEUTICS Ltd (9)
Big Cypress Acquisition Corp. (1)
bioAffinity Technologies, Inc. (3)
BioAtla, Inc. (1)
BioCardia, Inc. (1)
BIOCEPT INC (3)
BioLife4D Corp (2)
BIOMARIN PHARMACEUTICAL INC (1)
BIOSPECIFICS TECHNOLOGIES CORP (2)
Bison Capital Acquisition Corp. (1)
Black Diamond Therapeutics, Inc. (2)
Blue Water Vaccines Inc. (4)
bluebird bio, Inc. (6)
Bolt Biotherapeutics, Inc. (1)
Bone Biologics Corp (1)
BriaCell Therapeutics Corp. (2)
Cabaletta Bio, Inc. (4)
CALADRIUS BIOSCIENCES, INC. (2)
CAPRICOR THERAPEUTICS, INC. (1)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (2)
Capstone Therapeutics Corp. (3)
CASTLE BIOSCIENCES INC (2)
CATALYST BIOSCIENCES, INC. (1)
Celldex Therapeutics, Inc. (5)
Cellectar Biosciences, Inc. (1)
Chanticleer Holdings, Inc. (1)
Chardan Healthcare Acquisition 2 Corp. (1)
Checkpoint Therapeutics, Inc. (2)
ChemoCentryx, Inc. (1)
CLEVELAND BIOLABS INC (1)
Clovis Oncology, Inc. (1)
Coherus BioSciences, Inc. (2)
COMPASS Pathways plc (2)
Consonance-HFW Acquisition Corp. (2)
CRISPR Therapeutics AG (1)
CTI BIOPHARMA CORP (1)
Cullinan Oncology, LLC (2)
CURIS INC (1)
CytoDyn Inc. (1)
CYTORI THERAPEUTICS, INC. (2)
CYTRX CORP (2)
Dermavant Sciences Ltd (2)
Diffusion Pharmaceuticals Inc. (3)
DYADIC INTERNATIONAL INC (4)
Dynamics Special Purpose Corp. (2)
DYNAVAX TECHNOLOGIES CORP (3)
Editas Medicine, Inc. (1)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (2)
Emerald Bioscience, Inc. (2)
Emergent BioSolutions Inc. (6)
Enochian Biosciences Inc (3)
Esperion Therapeutics, Inc. (1)
Evelo Biosciences, Inc. (2)
EVOLUTIONARY GENOMICS, INC. (1)
EXACT SCIENCES CORP (2)
EXICURE, INC. (1)
FENNEC PHARMACEUTICALS INC. (5)
Fibrocell Science, Inc. (1)
FIBROGEN INC (1)
FIVE PRIME THERAPEUTICS INC (1)
Flexion Therapeutics Inc (3)
GALECTIN THERAPEUTICS INC (3)
Galecto Inc. (1)
Galera Therapeutics, Inc. (1)
Gemphire Therapeutics Inc. (1)
Gene Biotherapeutics, Inc. (1)
GENEREX BIOTECHNOLOGY CORP (1)
Genprex, Inc. (1)
GERON CORP (3)
GLYCOMIMETICS INC (1)
Greater Cannabis Company, Inc. (3)
GT Biopharma, Inc. (8)
GTX INC (1)
HCW Biologics Inc. (2)
Health Sciences Acquisitions Corp (6)
HEAT BIOLOGICS, INC. (3)
HEMISPHERX BIOPHARMA INC (9)
HERON THERAPEUTICS, INC. (1)
HilleVax, Inc. (1)
HOOKIPA Pharma Inc. (1)
HUMANIGEN, INC (2)
Immix Biopharma, Inc. (3)
Immune Therapeutics, Inc. (1)
Immuneering Corp (1)
ImmunoCellular Therapeutics, Ltd. (6)
Immunome Inc. (1)
IMMUNOMEDICS INC (2)
Inhibrx, Inc. (4)
INSMED Inc (4)
Intec Parent Inc. (1)
Intellia Therapeutics, Inc. (2)
INTERCEPT PHARMACEUTICALS, INC. (6)
INTREXON CORP (3)
IO Biotech, Inc. (5)
IONIS PHARMACEUTICALS INC (7)
IOVANCE BIOTHERAPEUTICS, INC. (2)
IRONWOOD PHARMACEUTICALS INC (1)
Isoray, Inc. (6)
iTeos Therapeutics, Inc. (1)
Janux Therapeutics, Inc. (1)
KalVista Pharmaceuticals, Inc. (3)
KBL MERGER CORP. IV (1)
Kindred Biosciences, Inc. (2)
Kiromic Biopharma, Inc. (1)
Kura Oncology, Inc. (2)
Lantern Pharma Inc. (1)
LifeSci Acquisition Corp. (1)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (3)
Locust Walk Acquisition Corp. (2)
MACROGENICS INC (1)
Magenta Therapeutics, Inc. (1)
MARIZYME INC (3)
Marker Therapeutics, Inc. (1)
MATEON THERAPEUTICS INC (2)
MEDICINOVA INC (4)
Medovex Corp. (1)
MiNK Therapeutics, Inc. (2)
MIRAGEN THERAPEUTICS, INC. (4)
Monte Rosa Therapeutics, Inc. (2)
MUSTANG BIO, INC. (3)
MYMETICS CORP (1)
Myovant Sciences Ltd. (9)
NantKwest, Inc. (6)
Natera, Inc. (4)
NAVIDEA BIOPHARMACEUTICALS, INC. (2)
NEUROBIOLOGICAL TECHNOLOGIES INC (3)
NEUROTROPE BIOSCIENCE, INC. (4)
Neurotrope, Inc. (5)
NEWLINK GENETICS CORP (1)
NORTHWEST BIOTHERAPEUTICS INC (6)
NOVAVAX INC (5)
NTN BUZZTIME INC (1)
OncBioMune Pharmaceuticals, Inc (1)
ONCOSEC MEDICAL Inc (1)
Opko Health, Inc. (1)
Orchard Therapeutics plc (2)
Organicell Regenerative Medicine, Inc. (1)
Orgenesis Inc. (5)
PALATIN TECHNOLOGIES INC (2)
Pfenex Inc. (2)
PharmaCyte Biotech, Inc. (1)
PhaseBio Pharmaceuticals Inc (2)
PIERIS PHARMACEUTICALS, INC. (1)
POLARITYTE, INC. (1)
PORTOLA PHARMACEUTICALS INC (2)
PROGENITY, INC. (2)
ProMIS Neurosciences Inc. (4)
Propanc Biopharma, Inc. (2)
Protagenic Therapeutics, Inc. (3)
PROTEON THERAPEUTICS INC (3)
PROTEOSTASIS THERAPEUTICS, INC. (1)
PTC THERAPEUTICS, INC. (2)
Q BioMed Inc. (1)
Qrons Inc. (7)
Radius Health, Inc. (15)
REXAHN PHARMACEUTICALS, INC. (1)
Rezolute, Inc. (2)
RHYTHM PHARMACEUTICALS, INC. (1)
RITTER PHARMACEUTICALS INC (1)
Savara Inc (3)
SEATTLE GENETICS INC (1)
Sensei Biotherapeutics, Inc. (1)
SERA PROGNOSTICS, INC. (1)
Sesen Bio, Inc. (1)
Shattuck Labs, Inc. (1)
Shuttle Pharmaceuticals Holdings, Inc. (2)
Silverback Therapeutics, Inc. (2)
Social Capital Suvretta Holdings Corp. III (10)
Sorrento Therapeutics, Inc. (1)
SPHERIX INC (2)
Spinning Eagle Acquisition Corp. (3)
Spring Bank Pharmaceuticals, Inc. (4)
SUNESIS PHARMACEUTICALS INC (9)
SYNLOGIC, INC. (9)
TG THERAPEUTICS, INC. (2)
Tonix Pharmaceuticals Holding Corp. (1)
TScan Therapeutics, Inc. (2)
U.S. Stem Cell, Inc. (2)
Ultragenyx Pharmaceutical Inc. (1)
Unicycive Therapeutics, Inc. (1)
uniQure N.V. (1)
United Therapeutics Corp (3)
Unity Biotechnology, Inc. (1)
VACCINEX, INC. (1)
Vaccitech plc (1)
Vaxart, Inc. (6)
VBI Vaccines Inc (8)
VERACYTE, INC. (2)
Vericel Corp (8)
Vigil Neuroscience, Inc. (2)
Viking Therapeutics, Inc. (3)
VistaGen Therapeutics, Inc. (2)
VITAL THERAPIES INC (15)
WINDTREE THERAPEUTICS INC (2)
Xencor Inc (1)
Xenetic Biosciences, Inc. (7)
Xilio Therapeutics, Inc. (2)
ZAFGEN, INC. (2)

Recent Contracts

Amended and Restated Transitional Services Agreement between 2seventy bio, Inc. and Nick Leschly, dated as of March 29, 2024 (2seventy bio, Inc., Filed With SEC on April 1, 2024)
Amended and Restated Transitional Services Agreement between 2seventy bio, Inc. and Nick Leschly, dated as of March 29, 2024 (incorporated by reference to the Current Report on... (2seventy bio, Inc., Filed With SEC on April 1, 2024)
Amendment No. 7 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated January 31, 2024 (Atara Biotherapeutics, Inc., Filed With SEC on March 28, 2024)
Amendment No. 6 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated December 30, 2023 (Atara Biotherapeutics, Inc., Filed With SEC on March 28, 2024)
Project Agreement dated January 2, 2024 with Patheon Manufacturing Services LLC, part of Thermo Fisher Scientific (GLYCOMIMETICS INC, Filed With SEC on March 27, 2024)
Amendment No. 2 to Services Agreement with Michael Breen, dated as of February 20, 2023 (GT Biopharma, Inc., Filed With SEC on March 26, 2024)
Amendment No. 3 to Master Services Agreement, dated August 3, 2023, by and between X4 Pharmaceuticals Inc., and Catalent (Arsanis, Inc., Filed With SEC on March 21, 2024)
Addendum to Statement of Work dated December 8, 2023 pursuant to Master Contract Services Agreement between Synlogic, Inc. and Azzur Group (d/b/a Azzur of New England LLC), SOW... (SYNLOGIC, INC., Filed With SEC on March 19, 2024)
Master Manufacturing Services Agreement and Product Agreement, dated August 3, 2015, by and between the Registrant and Patheon Pharmaceuticals Inc (ACADIA PHARMACEUTICALS INC, Filed With SEC on February 28, 2024)
Placement Agent and Advisory Services Agreement, dated February 7, 2024, between Shuttle Pharmaceuticals Holdings, Inc. and Boustead Securities, LLC (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on February 13, 2024)
Transitional Services Agreement between 2seventy bio, Inc. and Nick Leschly, dated as of January 29, 2024 (2seventy bio, Inc., Filed With SEC on January 30, 2024)
Biologics Master Services Agreement, effective June 20, 2022, by and between Paragon Therapeutics, Inc. and WuXi Biologics (Hong Kong) Limited (Aeglea BioTherapeutics, Inc., Filed With SEC on December 22, 2023)
Fifth Addendum, dated December 18, 2023, to Service Agreement between Immunic AG and Dr. Hella Kohlhof (VITAL THERAPIES INC, Filed With SEC on December 21, 2023)
Fifth Addendum, dated December 18, 2023, to Service Agreement between Immunic AG and Dr. Andreas Muehler (VITAL THERAPIES INC, Filed With SEC on December 21, 2023)
Fifth Addendum, dated December 18, 2023, to Service Agreement between Immunic AG and Dr. Daniel Vitt (VITAL THERAPIES INC, Filed With SEC on December 21, 2023)
Form of Shared Services Agreement between NightHawk Biosciences, Inc. and Elusys Holdings Inc (HEAT BIOLOGICS, INC., Filed With SEC on December 12, 2023)
Second Amended and Restated Commercial Manufacturing Services Agreement by and between the Company and WuXi Biologics (Hong Kong) Limited, dated September 19, 2023 (Adagio Therapeutics, Inc., Filed With SEC on November 9, 2023)
Consultancy Service Agreement between Hookipa Biotech GmbH and Malte Peters, effective September 15, 2023 (HOOKIPA Pharma Inc., Filed With SEC on November 9, 2023)
Service Framework Agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U. dated June 30, 2017 (DYADIC INTERNATIONAL INC, Filed With SEC on November 8, 2023)
Second Amendment to Master Manufacturing Services Agreement, dated September 21, 2023, by and between the Registrant and Lonza Houston, Inc (bluebird bio, Inc., Filed With SEC on November 7, 2023)
Amendment No.1 to Service Agreement, dated July 24, 2023, by and between BicycleTx Limited and Kevin Lee (BICYCLE THERAPEUTICS Ltd, Filed With SEC on November 2, 2023)
Amendment No. 5 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated September 27, 2023 (Atara Biotherapeutics, Inc., Filed With SEC on November 1, 2023)
Biologics Master Services Agreement, effective June 20, 2022, by and between Paragon Therapeutics, Inc. and WuXi Biologics (Hong Kong) Limited (Aeglea BioTherapeutics, Inc., Filed With SEC on October 10, 2023)
Assignment and Assumption Agreement, effective September 18, 2023, by and between Precision Pathology Laboratory Services, LLC and Village Oaks Pathology Services, P.A (bioAffinity Technologies, Inc., Filed With SEC on September 20, 2023)
Professional Services Agreement, effective as of September 18, 2023, by and between Precision Pathology Laboratory Services, LLC and Village Oaks Pathology Services, P.A (bioAffinity Technologies, Inc., Filed With SEC on September 20, 2023)
Succession Agreement, effective September 18, 2023, by and among, Precision Pathology Laboratory Services, LLC, Dr. Roby P. Joyce and Village Oaks Pathology Services, P.A (bioAffinity Technologies, Inc., Filed With SEC on September 20, 2023)
Advisory Services Agreement effective June 14, 2023 between the Registrant and Gunnar F. Kaufmann, Ph.D (GTX INC, Filed With SEC on August 10, 2023)
Sub-Contracting Manufacturing Services Agreement, dated July 28, 2023, between the Company and uBriGene (Boston) Biosciences, Inc (MUSTANG BIO, INC., Filed With SEC on July 31, 2023)
Manufacturing Services Agreement, dated July 28, 2023, between the Company and uBriGene (Boston) Biosciences, Inc (MUSTANG BIO, INC., Filed With SEC on July 31, 2023)
Amendment No. 1 to Master Services Agreement by and between Vistagen Therapeutics, Inc. and Allucent, dated June 24, 2022 (VistaGen Therapeutics, Inc., Filed With SEC on June 28, 2023)
Master Service and Technology Agreement dated May 9, 2023 (BriaCell Therapeutics Corp., Filed With SEC on June 14, 2023)
Master Service and Technology Agreement dated May 9, 2023 (BriaCell Therapeutics Corp., Filed With SEC on May 15, 2023)
Amendment to Master Services Agreement by and between the Company and Alwaysraise, LLC dated as of May 12, 2023 (Immix Biopharma, Inc., Filed With SEC on May 12, 2023)
Amendment No. 1 to Service Agreement, dated February 20, 2023, by and between BicycleTx Limited and Alistair Milnes (BICYCLE THERAPEUTICS Ltd, Filed With SEC on May 4, 2023)
Amendment No. 1 to Service Agreement, dated February 27, 2023, by and between BicycleTx Limited and Dominic Smethurst (BICYCLE THERAPEUTICS Ltd, Filed With SEC on May 4, 2023)
Amendment No. 1 to Service Agreement, dated February 20, 2023, by and between BicycleTx Limited and Nigel Crockett (BICYCLE THERAPEUTICS Ltd, Filed With SEC on May 4, 2023)
Amendment No. 2 to Service Agreement, dated February 20, 2023, by and between BicycleTx Limited and Michael Skynner (BICYCLE THERAPEUTICS Ltd, Filed With SEC on May 4, 2023)
Letter Regarding Service Agreement, dated April 13, 2023, by and between Jasper Therapeutics, Inc. and William Lis (Amplitude Healthcare Acquisition Corp, Filed With SEC on April 14, 2023)
Independent Contractor Services Agreement with Casper H. J. van Eijck (HEMISPHERX BIOPHARMA INC, Filed With SEC on April 7, 2023)
December 5, 2022 Master Service Agreement between Sterling Pharma Solutions Limited and AIM ImmunoTech Inc (HEMISPHERX BIOPHARMA INC, Filed With SEC on March 31, 2023)